Low-dose rivaroxaban associated with lower incidence of all-cause mortality and bleeding complications in older patients with non-valvular atrial fibrillation

27 August 2021 (08:00 - 20:00)
Organised by:
Congress Presentation Part of: Cardiovascular Disease in Special Populations ePosters Cardiovascular Disease in the Elderly ESC Premium Access ESC Congress 2021 - The Digital Experience